연구성과로 돌아가기
2021 연구성과별 연구자 정보 (1799 / 2991)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Multicenter Analysis of Clinical Features and Prognosis of COVID-19 Patients with Hepatic Impairment | Jang, Won Young | Jang, WY | 12 | Keimyung Univ, Dept Internal Med, Sch Med, Daegu, South Korea | chung50@dsmc.or.kr;kbs9225@cu.ac.kr; | |||||
| Multicenter Analysis of Clinical Features and Prognosis of COVID-19 Patients with Hepatic Impairment | Suh, Jeong Ill | Suh, JI | 13 | Dongguk Univ, Dept Internal Med, Coll Med, Gyeongju, South Korea | chung50@dsmc.or.kr;kbs9225@cu.ac.kr; | |||||
| Multicenter Analysis of Clinical Features and Prognosis of COVID-19 Patients with Hepatic Impairment | Chung, Woo Jin | Chung, WJ | 14 | 교신저자 | Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea | chung50@dsmc.or.kr;kbs9225@cu.ac.kr; | ||||
| Multicenter Analysis of Clinical Features and Prognosis of COVID-19 Patients with Hepatic Impairment | Kim, Byung Seok | Kim, BS | 15 | 교신저자 | Daegu Catholic Univ, Dept Internal Med, Sch Med, Daegu, South Korea | A-6076-2015 | Kim, Seul Kee | chung50@dsmc.or.kr;kbs9225@cu.ac.kr; | ||
| Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer (vol 51, pg 482, 2015) | Ryu, Min-Hee | Ryu, MH | 1 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, 88 Olymp Ro 43 Gil, Seoul 138736, South Korea | ykkang@amc.seoul.kr; | |||||
| Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer (vol 51, pg 482, 2015) | Yoo, Changhoon | Yoo, C | 2 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, 88 Olymp Ro 43 Gil, Seoul 138736, South Korea | ykkang@amc.seoul.kr; | |||||
| Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer (vol 51, pg 482, 2015) | Kim, Jong Gwang | Kim, JG | 3 | Kyungpook Natl Univ, Med Ctr, Dept Oncol Hematol, Daegu, South Korea | N-1450-2019 | Kim, Ju-Hyoung | ykkang@amc.seoul.kr; | |||
| Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer (vol 51, pg 482, 2015) | Ryoo, Baek-Yeol | Ryoo, BY | 4 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, 88 Olymp Ro 43 Gil, Seoul 138736, South Korea | ykkang@amc.seoul.kr; | |||||
| Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer (vol 51, pg 482, 2015) | Park, Young Soo | Park, YS | 5 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea | ykkang@amc.seoul.kr; | |||||
| Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer (vol 51, pg 482, 2015) | Park, Sook Ryun | Park, SR | 6 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, 88 Olymp Ro 43 Gil, Seoul 138736, South Korea | GMX-1199-2022 | Park, Se Hoon | ykkang@amc.seoul.kr; | |||
| Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer (vol 51, pg 482, 2015) | Han, Hye-Suk | Han, HS | 7 | Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea | ykkang@amc.seoul.kr; | |||||
| Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer (vol 51, pg 482, 2015) | Chung, Ik Joo | Chung, IJ | 8 | Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea | ykkang@amc.seoul.kr; | |||||
| Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer (vol 51, pg 482, 2015) | Song, Eun-Kee | Song, EK | 9 | Chonbuk Natl Univ, Sch Med, Dept Internal Med, Jeonju, South Korea | ykkang@amc.seoul.kr; | |||||
| Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer (vol 51, pg 482, 2015) | Lee, Kyung Hee | Lee, KH | 10 | Yeungnam Univ, Coll Med, Med Ctr, Dept Internal Med, Daegu, South Korea | ykkang@amc.seoul.kr; | |||||
| Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer (vol 51, pg 482, 2015) | Kang, Seok Yun | Kang, SY | 11 | Ajou Univ, Sch Med, Dept Hematol Oncol, Suwon, South Korea | ykkang@amc.seoul.kr; |
페이지 이동: